#adherence
- The GLP-1 Adherence Crisis 2026-03-19
Most GLP-1 patients stop within a year. Here's why adherence — not efficacy — is the defining challenge in metabolic therapy.
Tags: glp-1, metabolic health, adherence, health policy
Most GLP-1 patients stop within a year. Here's why adherence — not efficacy — is the defining challenge in metabolic therapy.